Published in J Clin Microbiol on January 21, 2009
Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences. Proc Natl Acad Sci U S A (2014) 2.63
Disease manifestations and pathogenic mechanisms of group a Streptococcus. Clin Microbiol Rev (2014) 2.20
New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci. Vaccine (2011) 1.98
Emergence of a New Highly Successful Acapsular Group A Streptococcus Clade of Genotype emm89 in the United Kingdom. MBio (2015) 1.54
Type I interferon production induced by Streptococcus pyogenes-derived nucleic acids is required for host protection. PLoS Pathog (2011) 1.36
Potential coverage of a multivalent M protein-based group A streptococcal vaccine. Vaccine (2013) 1.32
A decade of molecular pathogenomic analysis of group A Streptococcus. J Clin Invest (2009) 1.30
A molecular trigger for intercontinental epidemics of group A Streptococcus. J Clin Invest (2015) 1.29
Trading Capsule for Increased Cytotoxin Production: Contribution to Virulence of a Newly Emerged Clade of emm89 Streptococcus pyogenes. MBio (2015) 1.24
Genomic analysis of emm59 group A Streptococcus invasive strains, United States. Emerg Infect Dis (2012) 1.10
Group A streptococci clones associated with invasive infections and pharyngitis in Portugal present differences in emm types, superantigen gene content and antimicrobial resistance. BMC Microbiol (2012) 1.08
Characteristics of group A Streptococcus strains circulating during scarlet fever epidemic, Beijing, China, 2011. Emerg Infect Dis (2013) 1.05
Epidemiological and molecular analysis of Streptococcus pyogenes isolates causing invasive disease in Spain (1998-2009): comparison with non-invasive isolates. Eur J Clin Microbiol Infect Dis (2011) 1.04
Molecular analysis of an outbreak of lethal postpartum sepsis caused by Streptococcus pyogenes. J Clin Microbiol (2013) 1.04
Epidemiology of invasive Streptococcus pyogenes infections in France in 2007. J Clin Microbiol (2011) 1.02
Streptococcus pyogenes isolates causing severe infections in Norway in 2006 to 2007: emm types, multilocus sequence types, and superantigen profiles. J Clin Microbiol (2009) 0.99
Clinical and microbiologic characteristics of invasive Streptococcus pyogenes infections in north and south India. J Clin Microbiol (2012) 0.94
Nationwide laboratory-based surveillance of invasive beta-haemolytic streptococci in Denmark from 2005 to 2011. Clin Microbiol Infect (2013) 0.92
Transcriptome Remodeling Contributes to Epidemic Disease Caused by the Human Pathogen Streptococcus pyogenes. MBio (2016) 0.92
Epidemiology and molecular characterization of macrolide-resistant Streptococcus pyogenes in Taiwan. J Clin Microbiol (2013) 0.92
Virulence gene pool detected in bovine group C Streptococcus dysgalactiae subsp. dysgalactiae isolates by use of a group A S. pyogenes virulence microarray. J Clin Microbiol (2011) 0.91
Full-Length Genome Sequence of Type M/emm83 Group A Streptococcus pyogenes Strain STAB1101, Isolated from Clustered Cases in Brittany. Genome Announc (2015) 0.90
Clonal spread of Streptococcus pyogenes emm44 among homeless persons, Rennes, France. Emerg Infect Dis (2011) 0.89
Invasive group A streptococcal infection and vaccine implications, Auckland, New Zealand. Emerg Infect Dis (2011) 0.89
Lactobacilli reduce cell cytotoxicity caused by Streptococcus pyogenes by producing lactic acid that degrades the toxic component lipoteichoic acid. Antimicrob Agents Chemother (2011) 0.89
Protective immunogenicity of group A streptococcal M-related proteins. Clin Vaccine Immunol (2015) 0.89
The contribution of group A streptococcal virulence determinants to the pathogenesis of sepsis. Virulence (2013) 0.87
Comparative genomics analysis of Streptococcus isolates from the human small intestine reveals their adaptation to a highly dynamic ecosystem. PLoS One (2013) 0.87
Changing epidemiology of Streptococcus pyogenes emm types and associated invasive and noninvasive infections in Southern Taiwan. J Clin Microbiol (2009) 0.87
Consequences of the variability of the CovRS and RopB regulators among Streptococcus pyogenes causing human infections. Sci Rep (2015) 0.87
Superantigen gene complement of Streptococcus pyogenes--relationship with other typing methods and short-term stability. Eur J Clin Microbiol Infect Dis (2012) 0.86
Spread of a highly mucoid Streptococcus pyogenes emm3/ST15 clone. BMC Infect Dis (2010) 0.86
Clinical and microbial characteristics of invasive Streptococcus pyogenes disease in New Caledonia, a region in Oceania with a high incidence of acute rheumatic fever. J Clin Microbiol (2009) 0.85
Ongoing outbreak of invasive and non-invasive disease due to group A Streptococcus (GAS) type emm66 among homeless and people who inject drugs in England and Wales, January to December 2016. Euro Surveill (2017) 0.83
Streptococcus pyogenes bacteraemia, emm types and superantigen profiles. Eur J Clin Microbiol Infect Dis (2011) 0.82
Distribution of emm types in invasive and non-invasive group A and G streptococci. Eur J Clin Microbiol Infect Dis (2011) 0.82
Complete Genome Sequence of Streptococcus pyogenes M/emm44 Strain STAB901, Isolated in a Clonal Outbreak in French Brittany. Genome Announc (2014) 0.81
Seven-year surveillance of emm types of pediatric Group A streptococcal pharyngitis isolates in Western Greece. PLoS One (2013) 0.81
Increased cytotoxicity and streptolysin O activity in group G streptococcal strains causing invasive tissue infections. Sci Rep (2015) 0.81
emm gene diversity, superantigen gene profiles and presence of SlaA among clinical isolates of group A, C and G streptococci from western Norway. Eur J Clin Microbiol Infect Dis (2010) 0.81
Structural conservation, variability, and immunogenicity of the T6 backbone pilin of serotype M6 Streptococcus pyogenes. Infect Immun (2014) 0.80
Closed Genome Sequence of Noninvasive Streptococcus pyogenes M/emm3 Strain STAB902. Genome Announc (2014) 0.80
Antibacterial activity of the contact and complement systems is blocked by SIC, a protein secreted by Streptococcus pyogenes. J Biol Chem (2010) 0.79
Identification of group A streptococcal emm types commonly associated with invasive infections and antimicrobial resistance by the use of multiplex PCR and high-resolution melting analysis. Eur J Clin Microbiol Infect Dis (2012) 0.79
Epidemiology of invasive group A streptococcal infections in Norway 2010-2014: A retrospective cohort study. Eur J Clin Microbiol Infect Dis (2016) 0.79
Invasive group A streptococcal infection in children: clinical manifestations and molecular characterization in a French pediatric tertiary care center. Eur J Clin Microbiol Infect Dis (2010) 0.78
Epidemiology and emm types of invasive group A streptococcal infections in Finland, 2008-2013. Eur J Clin Microbiol Infect Dis (2015) 0.78
Serological Evidence of Immune Priming by Group A Streptococci in Patients with Acute Rheumatic Fever. Front Microbiol (2016) 0.78
Evaluation of emm gene types, toxin gene profiles and clonal relatedness of group A streptococci. Bosn J Basic Med Sci (2013) 0.78
Determining antibody-binding site of streptococcal pyrogenic exotoxin B to protect mice from group a streptococcus infection. PLoS One (2013) 0.78
Superantigenic activity of emm3 Streptococcus pyogenes is abrogated by a conserved, naturally occurring smeZ mutation. PLoS One (2012) 0.78
Lactobacilli Interfere with Streptococcus pyogenes Hemolytic Activity and Adherence to Host Epithelial Cells. Front Microbiol (2016) 0.77
Genomic Characteristics Behind the Spread of Bacteremic Group A Streptococcus Type emm89 in Finland, 2004-2014. J Infect Dis (2016) 0.77
Subtyping of emm1 group A Streptococci causing invasive infections in France. J Clin Microbiol (2009) 0.77
Streptococcus pyogenes emm Types and Clusters during a 7-Year Period (2007 to 2013) in Pharyngeal and Nonpharyngeal Pediatric Isolates. J Clin Microbiol (2015) 0.77
Molecular epidemiology of sil locus in clinical Streptococcus pyogenes strains. J Clin Microbiol (2014) 0.76
Application of the C3-binding motif of streptococcal pyrogenic exotoxin B to protect mice from invasive group a streptococcal infection. PLoS One (2015) 0.76
Streptococcus pyogenes Infection in a Free-Living European Hedgehog (Erinaceus europaeus). Ecohealth (2015) 0.76
Paediatric obstructive sleep apnoea syndrome (OSAS) is associated with tonsil colonisation by Streptococcus pyogenes. Sci Rep (2016) 0.76
Prevalence of M75 Streptococcus pyogenes Strains Harboring slaA Gene in Patients Affected by Pediatric Obstructive Sleep Apnea Syndrome in Central Italy. Front Microbiol (2017) 0.75
Immunization with a streptococcal multiple-epitope recombinant protein protects mice against invasive group A streptococcal infection. PLoS One (2017) 0.75
In Silico Investigation for Evaluation of the Potential of the SclA Protein in Streptococcus pyogenes. Jundishapur J Microbiol (2015) 0.75
Genome Analysis of Streptococcus pyogenes Associated with Pharyngitis and Skin Infections. PLoS One (2016) 0.75
Inhibitory role of acyl homoserine lactones in hemolytic activity and viability of Streptococcus pyogenes M6 S165. Sci Rep (2017) 0.75
Biofilm in group A streptococcal necrotizing soft tissue infections. JCI Insight (2016) 0.75
Recurrent sepsis caused by Streptococcus pyogenes. J Clin Microbiol (2011) 0.75
Blood Group Antigen Recognition via the Group A Streptococcal M Protein Mediates Host Colonization. MBio (2017) 0.75
Rapid Emergence of a New Clone Impacts the Population at Risk and Increases the Incidence of Type emm89 Group A Streptococcus Invasive Disease. Open Forum Infect Dis (2017) 0.75
Epidemiology and distribution of 10 superantigens among invasive Streptococcus pyogenes disease in Germany from 2009 to 2014. PLoS One (2017) 0.75
Necrotizing streptococcal myositis of the upper extremity: a case report. BMC Res Notes (2017) 0.75
The virulence factors of group A streptococcus strains isolated from invasive and non-invasive infections in Polish and German centres, 2009-2011. Eur J Clin Microbiol Infect Dis (2017) 0.75
Current insights in invasive group A streptococcal infections in pediatrics. Eur J Pediatr (2012) 0.75
An emm5 Group A Streptococcal Outbreak Among Workers in a Factory Manufacturing Telephone Accessories. Front Microbiol (2017) 0.75
An outbreak of invasive group A streptococcal infection among elderly patients receiving care from a district nursing team, October 2013 - May 2014. J Infect Prev (2015) 0.75
Have group A and B streptococcal infections become neglected diseases in Europe? Eur J Clin Microbiol Infect Dis (2017) 0.75
Pathogenesis of group A streptococcal infections. Clin Microbiol Rev (2000) 15.35
The global burden of group A streptococcal diseases. Lancet Infect Dis (2005) 13.58
Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med (1996) 8.41
Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol (1996) 6.28
What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin Microbiol Rev (2002) 5.81
The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis (2007) 5.36
Invasive group A streptococcus infections. Clin Infect Dis (1992) 4.82
Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections. JAMA (1993) 3.70
An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat Med (2002) 3.39
Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M protein. Nature (1981) 3.38
Location of variable and conserved epitopes among the multiple serotypes of streptococcal M protein. J Exp Med (1985) 3.23
emm typing and validation of provisional M types for group A streptococci. Emerg Infect Dis (1999) 3.12
Molecular basis of group A streptococcal virulence. Lancet Infect Dis (2003) 2.86
The serotypes of Streptococcus pyogenes present in Britain during 1980-1990 and their association with disease. J Med Microbiol (1993) 2.71
Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerg Infect Dis (1996) 2.51
Genome sequence of a serotype M28 strain of group a streptococcus: potential new insights into puerperal sepsis and bacterial disease specificity. J Infect Dis (2005) 2.45
Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect Immun (2000) 2.34
Genome-wide molecular dissection of serotype M3 group A Streptococcus strains causing two epidemics of invasive infections. Proc Natl Acad Sci U S A (2004) 2.32
Genetic correlates of throat and skin isolates of group A streptococci. J Infect Dis (1996) 2.06
Group A streptococci in the 1990s. J Antimicrob Chemother (2000) 1.87
Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol (2008) 1.81
The R28 protein of Streptococcus pyogenes is related to several group B streptococcal surface proteins, confers protective immunity and promotes binding to human epithelial cells. Mol Microbiol (1999) 1.79
Localization of protective epitopes of the amino terminus of type 5 streptococcal M protein. J Exp Med (1986) 1.71
A review of the correlation of T-agglutination patterns and M-protein typing and opacity factor production in the identification of group A streptococci. J Med Microbiol (1993) 1.69
Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin Infect Dis (2007) 1.66
Protective and nonprotective epitopes of chemically synthesized peptides of the NH2-terminal region of type 6 streptococcal M protein. J Immunol (1986) 1.54
Characterization of group A streptococci (Streptococcus pyogenes): correlation of M-protein and emm-gene type with T-protein agglutination pattern and serum opacity factor. J Med Microbiol (2006) 1.53
Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004. J Clin Microbiol (2007) 1.48
The flesh-eating bacterium: what's next? J Infect Dis (1999) 1.40
Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine. Clin Microbiol Infect (2008) 1.28
Current status of group A streptococcal vaccine development. Adv Exp Med Biol (2008) 1.25
Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes. Clin Diagn Lab Immunol (2005) 1.18
Identification and characterization of an antigen I/II family protein produced by group A Streptococcus. Infect Immun (2006) 1.14
Structure, function, and genetics of streptococcal M protein. Rev Infect Dis (1988) 1.13
emm Types, virulence factors, and antibiotic resistance of invasive Streptococcus pyogenes isolates from Italy: What has changed in 11 years? J Clin Microbiol (2007) 1.09
Epidemiological features of invasive and noninvasive group A streptococcal disease in the Netherlands, 1992-1996. Eur J Clin Microbiol Infect Dis (2004) 1.09
Invasive group A streptococcal disease in Alberta, Canada (2000 to 2002). J Clin Microbiol (2005) 1.06
Clonal spread of emm type 28 isolates of Streptococcus pyogenes that are multiresistant to antibiotics. J Clin Microbiol (2004) 1.06
Molecular characterization of Streptococcus pyogenes isolates to investigate an outbreak of puerperal sepsis. Infect Control Hosp Epidemiol (2005) 1.04
Invasive group A streptococcal infections in Sweden in 1994 and 1995: epidemiology and clinical spectrum. Scand J Infect Dis (2000) 1.04
Cross-protection between group A and group B streptococci due to cross-reacting surface proteins. J Infect Dis (2000) 1.00
Differential presentation of group A streptococcal superantigens by HLA class II DQ and DR alleles. Eur J Immunol (2002) 0.93
Genetic variation in the M antigen of group A streptococci: reassortment of type-specific markers and possible antigenic drift. J Infect Dis (1979) 0.89
Epidemiology of invasive Streptococcus pyogenes infections in Germany, 1996-2002: results from a voluntary laboratory surveillance system. Clin Microbiol Infect (2007) 0.89
[Surveillance of serious diseases caused by group A streptococci in the Czech Republic in 2003--the Strep-EURO project]. Epidemiol Mikrobiol Imunol (2004) 0.87
International quality assurance study for characterization of Streptococcus pyogenes. J Clin Microbiol (2007) 0.86
Host-pathogen interactions in Streptococcus pyogenes infections, with special reference to puerperal fever and a comment on vaccine development. Vaccine (2004) 0.85
Effects of a large-scale introduction of the pneumococcal polysaccharide vaccine among elderly persons in Stockholm, Sweden. Vaccine (2008) 0.84
Group A streptococcal infections: trend and strain emm typing in an area of central Italy, 1985-2002. Epidemiol Infect (2005) 0.83
Rapid pneumococcal evolution in response to clinical interventions. Science (2011) 9.09
Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA (2002) 4.48
Evolutionary origin and emergence of a highly successful clone of serotype M1 group a Streptococcus involved multiple horizontal gene transfer events. J Infect Dis (2005) 3.89
An endonuclease allows Streptococcus pneumoniae to escape from neutrophil extracellular traps. Curr Biol (2006) 3.69
Meticillin-resistant Staphylococcus aureus. Lancet Infect Dis (2005) 3.18
Reappraisal of the taxonomy of the Streptococcus bovis/Streptococcus equinus complex and related species: description of Streptococcus gallolyticus subsp. gallolyticus subsp. nov., S. gallolyticus subsp. macedonicus subsp. nov. and S. gallolyticus subsp. pasteurianus subsp. nov. Int J Syst Evol Microbiol (2003) 3.01
Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences. Proc Natl Acad Sci U S A (2014) 2.63
Bacterial adhesins in host-microbe interactions. Cell Host Microbe (2009) 2.43
Livestock-associated methicillin-resistant Staphylococcus aureus in humans, Europe. Emerg Infect Dis (2011) 2.35
Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections. Antimicrob Agents Chemother (2009) 2.12
Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies. J Exp Med (2007) 2.11
A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis. Proc Natl Acad Sci U S A (2006) 2.01
Extension of the Lancefield classification for group A streptococci by addition of 22 new M protein gene sequence types from clinical isolates: emm103 to emm124. Clin Infect Dis (2001) 2.00
Capsule and D-alanylated lipoteichoic acids protect Streptococcus pneumoniae against neutrophil extracellular traps. Cell Microbiol (2007) 1.99
Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis (2012) 1.97
Standardization of diagnostic PCR for the detection of foodborne pathogens. Int J Food Microbiol (2003) 1.95
Characterization of group B streptococci recovered from infants with invasive disease in England and Wales. Clin Infect Dis (2004) 1.91
Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: England and Wales, 1996-2006. J Infect (2009) 1.89
Clinical utility of PCR for common viruses in acute respiratory illness. Pediatrics (2014) 1.86
Emerging trends in the epidemiology of invasive group B streptococcal disease in England and Wales, 1991-2010. Clin Infect Dis (2013) 1.85
Evaluation of molecular typing methods in characterizing a European collection of epidemic methicillin-resistant Staphylococcus aureus strains: the HARMONY collection. J Clin Microbiol (2007) 1.85
Intraclonal variations among Streptococcus pneumoniae isolates influence the likelihood of invasive disease in children. J Infect Dis (2013) 1.84
Community-acquired methicillin-resistant Staphylococcus aureus, Finland. Emerg Infect Dis (2002) 1.83
A putative sugar-binding transcriptional regulator in a novel gene locus in Enterococcus faecalis contributes to production of biofilm and prolonged bacteremia in mice. J Infect Dis (2004) 1.82
Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol (2008) 1.81
Neutrophil extracellular traps: casting the NET over pathogenesis. Curr Opin Microbiol (2007) 1.80
Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet (2004) 1.77
Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin Infect Dis (2007) 1.66
Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm. J Infect Dis (2009) 1.64
Evaluation of the polymorphisms associated with tandem repeats for Pseudomonas aeruginosa strain typing. J Clin Microbiol (2003) 1.62
Toll-like receptor 9 acts at an early stage in host defence against pneumococcal infection. Cell Microbiol (2006) 1.62
Emergence of hypervirulent mutants resistant to early clearance during systemic serotype 1 pneumococcal infection in mice and humans. J Infect Dis (2014) 1.62
A multiplex PCR assay for the direct identification of the capsular type (Ia to IX) of Streptococcus agalactiae. J Microbiol Methods (2009) 1.61
Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany. Vaccine (2009) 1.56
Association of serotype of Streptococcus pneumoniae with risk of severe and fatal outcome. Pediatr Infect Dis J (2009) 1.55
The NLRP3 inflammasome is differentially activated by pneumolysin variants and contributes to host defense in pneumococcal pneumonia. J Immunol (2011) 1.54
The relationship between group A streptococcal infections and Tourette syndrome: a study on a large service-based cohort. Dev Med Child Neurol (2011) 1.53
Virulence in mice of pneumococcal clonal types with known invasive disease potential in humans. J Infect Dis (2005) 1.51
Variations in emm type among group A streptococcal isolates causing invasive or noninvasive infections in a nationwide study. J Clin Microbiol (2005) 1.50
Small molecule inhibitors of type III secretion in Yersinia block the Chlamydia pneumoniae infection cycle. FEBS Lett (2007) 1.50
Diphtheria in the postepidemic period, Europe, 2000-2009. Emerg Infect Dis (2012) 1.49
Streptococcus pneumoniae contains 3 rlrA pilus variants that are clonally related. J Infect Dis (2008) 1.49
Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004. J Clin Microbiol (2007) 1.48
Predictors of mortality in beta-hemolytic streptococcal bacteremia: a population-based study. J Infect (2009) 1.47
Multilocus sequence typing identifies evidence for recombination and two distinct lineages of Corynebacterium diphtheriae. J Clin Microbiol (2010) 1.47
Characterization of toxigenic Corynebacterium ulcerans strains isolated from humans and domestic cats in the United Kingdom. J Clin Microbiol (2005) 1.45
Central venous catheter infections and antibiotic therapy during long-term home parenteral nutrition: an 11-year follow-up study. JPEN J Parenter Enteral Nutr (2010) 1.45
Molecular epidemiology and distribution of serotypes, surface proteins, and antibiotic resistance among group B streptococci in Italy. J Clin Microbiol (2007) 1.44
Elimination of epidemic methicillin-resistant Staphylococcus aureus from a university hospital and district institutions, Finland. Emerg Infect Dis (2003) 1.43
Severe Streptococcus pyogenes infections, United Kingdom, 2003-2004. Emerg Infect Dis (2008) 1.43
Molecular epidemiology of macrolide-resistant Streptococcus pneumoniae isolates in Europe. J Clin Microbiol (2005) 1.41
ETosis: a novel cell death pathway. Sci Signal (2008) 1.41
Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003. Antimicrob Agents Chemother (2005) 1.35
Detection of large numbers of pneumococcal virulence genes in streptococci of the mitis group. J Clin Microbiol (2010) 1.32
Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective. BMC Infect Dis (2012) 1.29
Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe. Expert Rev Vaccines (2011) 1.29
Genetic diversity among type emm28 group A Streptococcus strains causing invasive infections and pharyngitis. J Clin Microbiol (2005) 1.26
Lysogenic transfer of group A Streptococcus superantigen gene among Streptococci. J Infect Dis (2008) 1.24
LytA, major autolysin of Streptococcus pneumoniae, requires access to nascent peptidoglycan. J Biol Chem (2012) 1.23
Mechanism for sortase localization and the role of sortase localization in efficient pilus assembly in Enterococcus faecalis. J Bacteriol (2009) 1.23
Tetracycline and macrolide co-resistance in Streptococcus pyogenes: co-selection as a reason for increase in macrolide-resistant S. pyogenes? Microb Drug Resist (2004) 1.23
Sortase-mediated assembly and surface topology of adhesive pneumococcal pili. Mol Microbiol (2008) 1.22
Clinical risk management in obstetrics: eclampsia drills. BMJ (2004) 1.21
Tsukamurella tyrosinosolvens intravascular catheter infection identified using 16S ribosomal DNA sequencing. Clin Infect Dis (2003) 1.21
Determination of accessory gene patterns predicts the same relatedness among strains of Streptococcus pneumoniae as sequencing of housekeeping genes does and represents a novel approach in molecular epidemiology. J Clin Microbiol (2007) 1.20
Pangenomic study of Corynebacterium diphtheriae that provides insights into the genomic diversity of pathogenic isolates from cases of classical diphtheria, endocarditis, and pneumonia. J Bacteriol (2012) 1.19
Streptococcus pneumoniae evades human dendritic cell surveillance by pneumolysin expression. EMBO Mol Med (2009) 1.19
Therapeutic failures of antibiotics used to treat macrolide-susceptible Streptococcus pyogenes infections may be due to biofilm formation. J Clin Microbiol (2006) 1.18
Clinical isolates of Streptococcus pneumoniae bind the complement inhibitor C4b-binding protein in a PspC allele-dependent fashion. J Immunol (2009) 1.18
Dominant role of nucleotide substitution in the diversification of serotype 3 pneumococci over decades and during a single infection. PLoS Genet (2013) 1.17
Emergence of macrolide-resistant Streptococcus pyogenes strains in French children. Antimicrob Agents Chemother (2004) 1.16
International nomenclature for Corynebacterium diphtheriae ribotypes. Res Microbiol (2004) 1.15
Carriage of methicillin-resistant Staphylococci and their SCCmec types in a long-term-care facility. J Clin Microbiol (2008) 1.15
Epidemiology of invasive Streptococcus pyogenes disease in Germany during 2003-2007. FEMS Immunol Med Microbiol (2010) 1.14
Multidrug and broad-spectrum cephalosporin resistance among Salmonella enterica serotype enteritidis clinical isolates in southern Italy. J Clin Microbiol (2002) 1.14
Group B streptococcus late-onset disease: 2003-2010. Pediatrics (2013) 1.13
Superantigen genes are more important than the emm type for the invasiveness of group A Streptococcus infection. J Infect Dis (2010) 1.11
Developmental switch of intestinal antimicrobial peptide expression. J Exp Med (2008) 1.11